CEACAM5 and neoplasm: Analysis of stage 0–IV patients revealed that serum TNC levels were weakly correlated with the inflammatory markers albumin and NLR and the tumor marker CA19-9 but not with the body composition marker BMI or the tumor marker carcinoembryonic antigen (CEA) (Fig. 3c).